Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002012383-26-003968·BlackRock, Inc.
Schedule 13G ownership disclosure
BioMarin Pharmaceutical Inc
Common Stock · CUSIP: 09061G101
Event date: 2026-10-31
- Filing-level shares
- 19,373,309
- Percent of class
- 10.0%
- BlackRock, Inc.
Shares: 19,373,309 · Class: 10.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-26-003968
- Form type
- SCHEDULE 13G/A
- Filer
- BlackRock, Inc.
- CIK
- CIK 2012383
- Filed
- Nov 04, 2026
- Reporting period
- Oct 31, 2026
- Description
- Schedule 13G beneficial ownership